Research study Program year 2019 Source: CMS Open Payments

Tralokinumab Drug Interaction Trail

ClinicalTrials.gov NCT03556592

Research payments

$669,016

71 payments

Through program year 2019, $669,016 in research payments was reported against Tralokinumab Drug Interaction Trail, across 71 payments, paid by LEO Pharma AS.

Paid by: LEO Pharma AS
ClinicalTrials.gov: NCT03556592

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$669,016	71

Breakdown

Who paid Research payments · program year 2019

LEO Pharma AS $669,016 71 payments

Who received the money Research payments · program year 2019

L & C Professional Medical Research Institute Organisation paid for research $292,159 8 payments
MD Strategies Research Centers LLC Organisation paid for research $115,776 13 payments
Revival Research Organisation paid for research $71,492 8 payments
Abrh LLC Organisation paid for research $64,951 21 payments
Leon Medical Research Organisation paid for research $59,491 7 payments
Beacon Clinical Research LLC Organisation paid for research $30,638 5 payments
Woodland Research Northwest LLC Organisation paid for research $26,962 7 payments
Applied Research Center Of Arkansas Organisation paid for research $5,750 1 payment
Virginia Clinical Research INC Organisation paid for research $1,797 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.